+
Site Tour

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

FIND OUT MORE ON AV VALVES SUMMIT 2024:

Watch on Demand videos

Related Videos

MitraClip - AVVS 1 year 1 minute Mitral - Video

Case Parade | Tricuspid focus

Navigating the Anatomy | Tricuspid focus

AV Valves Summit 2024 | Closing of Day 2

LAAO Summit - Ideal vs suboptimal LAAO implant

LAAO Summit 2023: Future perspectives

LAAO Summit - Imaging debate: TEE

LAAO Summit 2023: CT

LAAO Summit - LAAO with risk of leak

AV VALVES 2023: TR – Multileaflet Valve

AV VALVES 2023: Staged, Concomitant

AV VALVES 2023: Trending Topics – QoL

TRENDING TOPICS

Navigating the Anatomy | Tricuspid focus

Navigating the Anatomy | Tricuspid focus

F. Maisano, V. Delgado, P. Denti, M. Taramasso

Review the Trends | Tricuspid focus

Review the Trends | Tricuspid focus

M. Metra, G. Leurent, D. Tchetche, T. Nestelberger, D. Cohen, M. Adamo

Case Transmission | Tricuspid focus

Case Transmission | Tricuspid focus

F. Maisano, M. I. Koerber, H. Dreger, R. Bekeredjian, K. K. Yeo, T. Matsumoto

CONNEXT


TV
RELATED RESOURCES

Echo course mitral TEER – cases

MitraClip™ Patient Story: Scott

LAAO Summit 2023: Stroke severity

LAAO Summit - TEE vs CT leaks

CONNEXT


HUB
RELATED RESOURCES

EuroEcho 2021: Tricuspid regurgitation: The Patient

bRIGHT study

TriClip™ G4: Product overview

ESC 2021: HF & VHD Guidelines

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline